← Open Payments lookup

STEPHANIE PETTINGLE: Open Payments

NPI 1205258605 · SHELTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$377 in 16 payments from 7 companies in 2025. Trend: 2023 $75 · 2024 $275 · 2025 $377

Food & beverage: $377
CompanyPaymentsAmount
Novo Nordisk Inc6$138
Lilly USA, LLC4$96
Astellas Pharma US Inc2$60
ABBVIE INC.1$26
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$22
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$19
SANOFI-AVENTIS U.S. LLC1$18

Products named: MOUNJARO, Veozah, UBRELVY, Wegovy, CAPLYTA, XIFAXAN, Ozempic, TZIELD.

Industry payments across CT — which companies pay providers there.